"What if the next blockbuster drug isn’t a molecule – but a frequency?"

Electrome is leveraging AI to translate decades of bioelectric science into first-in-class treatments and novel combination therapies across high-burden disease areas.



This IS exciting, especially to those of us who have been following Biel for a while.
We shall see...when?
Your guess is as good as mine.
Patience....yes...patience is NOT all that's needed here..
For one of THE most anticipated news in Biotech of this decade, or shall I say century, owning shares in Biel could potentially set you up for life and future generations to come...

Stay tuned.